Incyte (INCY) Non-Current Assets (2010 - 2026)
Incyte (INCY) reported Non-Current Assets of $1.85 billion for Q2 2026, down 15.2% from $2.18 billion a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Incyte posted Non-Current Assets of $1.93 billion, down 12.3% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of 10.0% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $2.21 billion in FY2024 (+3.2%), $2.14 billion in FY2023 (+22.2%), $1.75 billion in FY2022 (-3.7%) and $1.81 billion in FY2021 (+51.1%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q1 2023.
- Year over year, Non-Current Assets has now declined in each of the last four quarters, with an average decline of 4.4% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q4 2021 (growth of 51.1%); the low point was Q1 2026 (a decline of 17.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.85 billion (Q1 2026), $1.93 billion (Q4 2025) and $2.05 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn | 1.85 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 Bn |
| Mar 31, 2026 | 1.85 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 2.05 Bn |
| Jun 30, 2025 | 2.18 Bn |
| Mar 31, 2025 | 2.24 Bn |
| Dec 31, 2024 | 2.21 Bn |
| Sep 30, 2024 | 2.20 Bn |
| Jun 30, 2024 | 2.09 Bn |
| Mar 31, 2024 | 2.29 Bn |
| Dec 31, 2023 | 2.14 Bn |
| Sep 30, 2023 | 1.99 Bn |
| Jun 30, 2023 | 1.94 Bn |
| Mar 31, 2023 | 1.83 Bn |
| Dec 31, 2022 | 1.75 Bn |
| Sep 30, 2022 | 1.69 Bn |
| Jun 30, 2022 | 1.69 Bn |
| Mar 31, 2022 | 1.77 Bn |
| Dec 31, 2021 | 1.81 Bn |
| Sep 30, 2021 | 1.28 Bn |
API Access
Incyte Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();